Garcia Monika, Gerber Ari, Zakhary Bishoy, Finco Tiago, Kazi Albert, Zhang Xiaofei, Brenner Megan, Coimbra Raul
Am Surg. 2019 Oct 1;85(10):1129-1133.
Best management for acute appendicitis (AA) in adults with liver cirrhosis is controversial and needs more investigation. We aimed to examine the impact of different treatment modalities on outcomes in this complex patient population. The Nationwide Inpatient Sample database from 2012 to 2014 was queried to identify AA patients with no cirrhosis, compensated cirrhosis (CC), and decompensated cirrhosis (DC). Each cohort was further stratified according to the treatment type: nonoperative management, open appendectomy, and laparoscopic appendectomy (LA). Chi-square, ANOVA, and binary regression analyses were used to determine differences between groups and risk factors for mortality and complications, with < 0.05 considered statistically significant. A total of 108,289 AA patients were analyzed; of those, 304 with CC and 134 with DC were identified. Compared with CC and no cirrhosis, DC patients had significantly higher mortality, higher cost, and longer hospital length of stay. LA is accompanied by higher survival, lower cost, shorter duration of hospitalization, and lower incidence of complications across all groups. We conclude that LA is the best management strategy for AA in cirrhotic patients. Even in decompensated cirrhotics, which are associated with worse clinical outcomes, LA is still a favorable option over open appendectomy and nonoperative management.
成人肝硬化患者急性阑尾炎(AA)的最佳治疗方法存在争议,需要更多研究。我们旨在研究不同治疗方式对这一复杂患者群体预后的影响。查询了2012年至2014年的全国住院患者样本数据库,以确定无肝硬化、代偿期肝硬化(CC)和失代偿期肝硬化(DC)的AA患者。每个队列根据治疗类型进一步分层:非手术治疗、开腹阑尾切除术和腹腔镜阑尾切除术(LA)。采用卡方检验、方差分析和二元回归分析来确定组间差异以及死亡率和并发症的危险因素,P<0.05被认为具有统计学意义。共分析了108289例AA患者;其中,确定了304例CC患者和134例DC患者。与CC和无肝硬化患者相比,DC患者的死亡率显著更高、费用更高且住院时间更长。所有组中,LA的生存率更高、费用更低、住院时间更短且并发症发生率更低。我们得出结论,LA是肝硬化患者AA的最佳治疗策略。即使在临床预后较差的失代偿期肝硬化患者中,LA仍然是优于开腹阑尾切除术和非手术治疗的选择。